Circulating Histones as Robust Liquid Biopsies for Cardiovascular Diseases & Cancer
Time: 2:00 pm
day: Conference Day Two - Track 1 - PM
Details:
- Increasing evidence suggests that circulating histones and histone complexes, originating from cell death or immune cell activation, could act as promising biomarkers for cancer detection and management
- Leveraging circulating histones as a powerful liquid biopsy approach and methods for their detection. Hghlighting current knowledge on circulating histones in hematologic malignancies and solid cancer, as well as in cardiovascular disease
- Describing potential artificial intelligence (AI)-based strategies to identify histone identity and cancer tissue-of-origin in blood plasma based on nucleosome positioning
